[CAS NO. 99533-80-9]  K-252a

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [99533-80-9]

Catalog
HY-N6732
Brand
MCE
CAS
99533-80-9

DESCRIPTION [99533-80-9]

Overview

MDL-
Molecular Weight467.47
Molecular FormulaC27H21N3O5
SMILESO=C(NC1)C2=C1C3=C4C5=C2C6=C(C=CC=C6)N5[C@](C[C@]7(O)C(OC)=O)([H])O[C@]7(C)N4C8=C3C=CC=C8

For research use only. We do not sell to patients.


Summary

K-252a, a staurosporine analog, inhibits protein kinase , with IC 50 values of 470 nM, 140 nM, 270 nM, and 1.7 nM for PKC , PKA , Ca 2+ /calmodulin-dependent kinase type II, and phosphorylase kinase, respectively [1] [2] . K-252a is a potent inhibitor (IC 50 of 3 nM) of the tyrosine protein kinase (TRK) activity of the NGF receptor gp140trk, the product of the trk protooncogene [3] .


IC50 & Target

CaMK II


In Vitro

K-252a (3-100 nM, 8d) inhibits NGF-promoted neurite outgrowth [5] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis [4] .

Cell Line: LINC00641-overexpressed cell line.
Concentration: 1.7 nM (NGF (50 ng/mL)).
Incubation Time: 6 h.
Result: Decreased p-Akt and p-TrkB levels.

Cell Viability Assay [5] .

Cell Line: PC12 subclone h cells.
Concentration: 3 to 100 nM.
Incubation Time: 8 d.
Result: Inhibited NGF-promoted neurite outgrowth.

In Vivo

K252a (20 mg/kg/day) inhibiting TrkB pathway dampens the neuroprotective effects induced by TH [6] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Mice [6] .
Dosage: 20 mg/kg/day.
Administration: Intraperitoneally, daily, for consecutive 5 days.
Result: Dampened the neuroprotective effects induced by TH.

Appearance

Solid


Source

Nocardiopsis sp.


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Powder -20°C 3 years
In solvent -80°C 6 months
-20°C 1 month

Solvent & Solubility

In Vitro:

DMSO : 50 mg/mL ( 106.96 mM ; Need ultrasonic and warming)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.1392 mL 10.6959 mL 21.3917 mL
5 mM 0.4278 mL 2.1392 mL 4.2783 mL
10 mM 0.2139 mL 1.0696 mL 2.1392 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

    Solubility: ≥ 2.5 mg/mL (5.35 mM); Clear solution

  • 2.

    Add each solvent one by one: 10% DMSO >> 90% corn oil

    Solubility: ≥ 2.08 mg/mL (4.45 mM); Clear solution

* All of the co-solvents are available by MCE.


Synonyms

9,12-Epoxy-1H-diindolo[1,2,3-fg:3′,2′,1′-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid, 2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-, methyl ester, (9S,10R,12R)-
9,12-Epoxy-1H-diindolo[1,2,3-fg:3′,2′,1′-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid, 2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-, methyl ester, [9S-(9α,10β,12α)]-
Antibiotic SF 2370
Antibiotic K 252a, (+)-
K 252a
SF 2370
(+)-Antibiotic K 252a
(+)-K 252a
(+)-Antibiotic SF 2370
(+)-SF 2370
Antibiotic K 252a
Antibiotic SF 2370, (+)-
Protein kinase inhibitor K252a
K 252
K 252a Nocardiopsis sp.